Takeda to sell Japan consumer health unit to Blackstone for $2B-plus: reports

The final—and the biggest—piece of Takeda’s $10 billion divestment plan could be wrapped up soon.

The Japanese pharma is in the final stage of talks to sell its domestic consumer health business to U.S. private equity firm Blackstone Group. The two companies aim to shake hands on the final version by the end of this month, Kyodo News reported Wednesday, citing sources close to the matter.